All Matthias Schnell articles
-
NewsFirst-in-human clinical trial shows promising results for new Lassa fever vaccine
Researchers have reported encouraging results from an early clinical trial that tested a new dual vaccine against Lassa fever and rabies. The study found that the vaccine was safe and induced immune responses against both viruses. There are currently no vaccines against Lassa fever on the market.
-
NewsNIH-sponsored trial of Lassa vaccine opens
A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.
-
NewsResearchers develop promising Lassa fever vaccine
Researchers have developed a promising new vaccine candidate that protects against Lassa fever. The vaccine effectively prevents severe cases of the disease and death in preclinical animal models and paves the way for research in people.